S100A7 and rheumatoid arthritis: Products of S100A7 and other alarmin family genes are involved in RA pathogenesis apart from their ligand-receptor process, and paclitaxel, a promoter of the nuclear translocation of S100A7, might be an abrogation strategy for gene therapy.